Walgreens settles with the DOJ for $350 million in opioid lawsuit
Briefly

Walgreens is set to pay up to $350 million to settle claims by the U.S. Department of Justice for allegedly illegal prescription fills of opioids over a decade. This includes a mandatory payment of $300 million and a potential additional $50 million if the company undergoes a sale before 2032. The government accused Walgreens of ignoring red flags on improperly filled prescriptions, manipulating pharmacist work conditions, and failing to act against unlawful prescribers. Despite denial of liability, Walgreens sees this settlement as a means to conclude all opioid-related litigation and shift focus to revitalizing its business.
Walgreens has agreed to a $350 million settlement with the U.S. Department of Justice over allegations of illegally filling millions of opioid prescriptions.
The settlement's terms dictate that Walgreens must pay at least $300 million upfront, with an additional $50 million contingent upon future company transactions.
Read at Fast Company
[
|
]